Team

Cancer researchers from the Icahn School of Medicine at Mount Sinai and other institutions across the country contribute to our research into p53 regulators and effectors.

Stuart A. Aaronson, MD
Icahn School of Medicine
Program Director, Leader Projects 1 and 3, Director Core A

Sam W. Lee, PhD
Massachusetts General Hospital
Co-Leader Project 1

James J. Manfredi, PhD 
Icahn School of Medicine
Co-Leader Project 2, Director Core B

Ming-Ming Zhou, PhD
Icahn School of Medicine
Leader Project 2

Wei Gu, PhD
Columbia University
Co-Principal Investigator Project 3

Ed Hicks, MBA, MA  
Icahn School of Medicine
Administrator

Contributors

C. David Allis, PhD
Rockefeller University
External Adviser

Fred Bunz, MD, PhD
Johns Hopkins
Collaborator

David Cowburn, PhD, DSc
New York Structural Biology Center
External Adviser

Adolfo García-Sastre, PhD 
Icahn School of Medicine
Collaborator

James H. Godbold, PhD  
Icahn School of Medicine
Collaborator

Kevin A. Kelley, PhD  
Icahn School of Medicine
Collaborator

Thomas M. Moran, PhD  
Icahn School of Medicine
Collaborator/Internal Adviser

Maureen Murphy, PhD
The Wistar Institute
External Advisor

Moshe Oren, PhD
Weizmann Institute of Science
External Adviser

Jun Qin, PhD
Baylor College of Medicine
Collaborator

Philippe M. Soriano, PhD  
Icahn School of Medicine
Collaborator/Internal Adviser

Martin J. Walsh, PhD  
Icahn School of Medicine
Internal Adviser

Shaomeng Wang, PhD
University of Michigan Medical School
Collaborator

Stuart H. Yuspa, PhD
National Institutes of Health, National Cancer Institute
Collaborator